TET2-Mutant Hematopoietic Clones Shape the Lung Immune Microenvironment in NSCLC Initiation and Progression
Final report summarizing my summer biological research on non-small cell lung cancer (NSCLC) and clonal hematopoiesis of indeterminate cell potential (CHIP) at the Francis Crick Institute in London, UK.
Like
Be the first to like this
Preview